Date | Programmes | Podcast Title | |
---|---|---|---|
19-Aug-22 |
Market Watch (7:00 AM) |
5.5% GDP Not Likely For China
Carlos Casanova, Senior Economist, UBP |
|
05-Jan-21 |
Morning Brief (7:37 AM) |
Turning The Taps Back On
Yong-Liang Por, Consultant, Institute for Energy Economics & Financial Analysis (IEEFA) |
|
14-May-20 |
Market Watch (7:00 AM) |
Message to Fed: More Sugar Please!
Tony Nash, Chief Executive Officer, Complete Intelligence |
|
23-Apr-20 |
Market Watch (8:30 AM) |
Ringgit's Fortunes Tied to Oil
Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank |
|
22-Apr-20 |
Morning Brief (9:15 AM) |
Oil, No Longer Black Gold
Peck Boon Soon, Chief Economist, RHB Research |
|
22-Apr-20 |
Market Watch (8:30 AM) |
Of Crude, Coronavirus, and Certainty
Jeffrey Halley, Senior Market Analyst, OANDA |
|
21-Apr-20 |
Market Watch (8:30 AM) |
Oil, the PPP, and a Return to Normalcy
Joe Quinlan, Chief Market Strategist, US Trust-BOA Private Wealth Management |
|
02-Apr-18 |
Market Watch (7:35 AM) |
"Investors Struggling With This New Normal"
Stephen Innes, Head of Trading in Asia-Pacific, OANDA, Singapore |
|
21-Jun-17 |
Market Watch (7:35 AM) |
MSCI Decision Could Put Pressure on Chinese Government
|
|
01-Jun-17 |
Market Watch (7:07 AM) |
OptionsXpress: Trade the Ranges with Oil
Ben LeBrun, Market Analyst, optionsXpress, Sydney |
|
29-May-17 |
Market Watch (9:20 AM) |
StanChart: MYR Strength to be Limited
Tariq Ali, Investment Strategist, Standard Chartered |
|
08-Mar-17 |
Market Watch (7:07 AM) |
Oil, Elections and Trigger-Happy Trump: Just Another Day in Global Markets
Dodge Dorland, Chief Investment Officer, Landor & Fuest Capital Managers |
|
23-Nov-16 |
Today's BizTalk (7:37 AM) |
Watching the Watchmen
The Morning Run Crew |
|
07-Sep-16 |
Market Watch (7:07 AM) |
US Markets Cools Down
|
|
12-Aug-16 |
Market Watch (7:07 AM) |
Why Oil Is Approaching Equilibrium
Manpreet Gill, Head of Fixed Income, Currencies, Commodities, Standard Chartered |
|
27-May-16 |
Market Watch (7:07 AM) |
Have Oil Prices Passed the Rubicon?
Tim Mulholland, Managing Partner, China-America Capital Company, Chicago |
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Tony Nash of Complete Intelligence tells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Heron Lim, Economist at Moody’s Analytics discusses the impact of Trump's tariffs on China's economy.
Morning Brief
Prof. Azmi Hassan, Political Analyst and Senior Fellow at the Nusantara Academy weighs in on the three cornered fight in the Ayer Kuning By-election
The Breakfast Grille
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Morning Brief
Dr Renato Lima de Oliveira, Institute of Democracy and Economic Affairs (IDEAS) discusses the depletion of natural gas reserves in Malaysia.
Opening Bell
(REPEAT) Tony Nash of Complete Intelligence tells us where international markets are heading.
Opening Bell
Christopher Wong, FX Strategist at OCBC speaks about the impact of Trump’s tariffs on Asian currencies.
Ringgit & Sense
Jennifer Chua, licensed Financial Advisor at UOB Kay Hian talks about the ins and outs of planning for your parents' aged care.
Open For Business
How Nexacore Aims to Solve the ‘Last Mile’ Problem in Device Insurance
Tech Talk
Breaking Up with Your Phone: The Case for a Digital Detox
Enterprise Explores
Inside Southeast Asia’s $19B Food Delivery Market
The Breakfast Grille Repeat
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Discovery Hour
An eclectic selection of BBC shows, curated with variety in mind.
Beyond the Ballot Box
In this conversation with Jomo Kwame Sundaram, we discuss what Trump’s tariffs reveal about neoliberalism and the dollar’s dominance.
Health & Living
How does the Ministry of Health decide what therapies are available in the public health system? And as more innovative and expensive therapies are developed, how do we balance cost with public need?
Top 5 at 5
BBC World Service